Respiratory Mechanics During One-lung Ventilation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04519606 |
|
Recruitment Status :
Completed
First Posted : August 19, 2020
Last Update Posted : October 7, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Ventilator-Induced Lung Injury Lung Ventilator One-lung Ventilation | Procedure: Optimal lung compliance during OLV |
Background One-lung ventilation (OLV) is the foremost used technique of ventilation during thoracic procedures. Intraoperative lung separation can be managed by means of double-lumen endotracheal tube (DLT), bronchial blocker (BB), or nonintubated method. OLV is impeded by significant reduction in lung volume, decline in lung compliance at lateral decubital position, formation of intrapulmonary shunting and exposure of the dependent lung to ventilator-induced lung injury (VILI). In addition, patients receiving thoracic surgeries are more prone to developing acute lung injuries due to direct surgery-related trauma caused by instrumentation or manipulation of the lung tissues, hypoperfusion induced by hypoxic pulmonary vasoconstriction, and dysfunction of surfactant system. The non-dependent lung is injured by surgical manipulation and atelectrauma. Re-expansion of the collapsed non-dependent lung at the end of surgery inevitably results in systemic inflammatory response in the local and contralateral lungs, which in turn leads to biotrauma. Therefore, a significantly high pulmonary complication of up to 14-28.4% was reported in patients that received OLV surgery.
In the recent two decades, there is a major paradigm shift for mechanical ventilator support during operation by the introduction of intraoperative lung protective ventilation strategies. Some of these changes include a low tidal volume (Vt), moderate levels of positive end-expiratory pressure (PEEP), optimal driving pressure (∆P) and the appropriate use of lung recruitment maneuver. Intraoperative lung protective ventilation strategies have been shown to reduce post-operative pulmonary complications and improve overall clinical outcomes in intermediate and high-risk patients undergoing major abdominal surgery. Currently, however, there is a lack of clinical evidence in regard to appropriate protective-lung strategies during OLV. The optimal levels of intraoperative use of oxygen fraction, the ventilatory settings for volume and pressure variables during OLV and re-expansion phases for lung recruitment are debating. The main objective of this clinical study is to determine the optimal levels of volume-pressure dynamics during OLV and at the phase of recruitment of the independent lungs by achieving optimal lung compliance, gas exchange and hemodynamics.
| Study Type : | Observational [Patient Registry] |
| Actual Enrollment : | 10 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 3 Days |
| Official Title: | Optimization of Respiratory Mechanics During One-lung Ventilation |
| Actual Study Start Date : | December 1, 2020 |
| Actual Primary Completion Date : | August 30, 2021 |
| Actual Study Completion Date : | September 30, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
One-lung ventilation
During one-lung ventilation, the dependent lung (non-operation lung) will be mechanically ventilated with a fixed positive end-expiratory pressure (PEEP) of 4 cmH2O and the peak pressure below 30 cmH2O. Tidal volumes will be titrated from the initial 4 ml/kg predicted body weight (PBW) to 7 ml/kg PBW. Optimal lung compliance is determined by the levels of upper reflection point of the pressure-volume loop closed to 30 cmH2O. Chest tomography will be undertaken with the optimal tidal volume during OLV phase and when the independent lung is completely recruited using the stepwise PEEP increase method.
|
Procedure: Optimal lung compliance during OLV
Stepwise increase of tidal volume from 4 ml/kg PBW to 7 ml/kg PBW during OLV to determine the optimal tidal volume at the level the the pressure-volume loop reaches upper refection point where the peak airway pressure at or just below 30 cmH2O |
- Optimal level of lung compliance during OLV [ Time Frame: During the OLV phase of thoracic surgery ]A tidal volume (4-7 ml/kg PBW) where the pressure-volume loop reaches upper refection point and the peak airway pressure at or just below 30 cmH2O
- Postoperative pulmonary complication [ Time Frame: 3 days after operation ]Composite endpoints of clinical diagnoses of pneumonia, bronchospasm, and/or ARDS), radiological diagnoses of atelectasis, pneumothorax, and/or pleural effusion, and therapies for respiratory insufficiency (need for prolonged therapy after end of surgery by providing supplemental oxygen, postoperative noninvasive ventilation, and/or reintubation with postoperative mechanical ventilation.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Scheduled for single lobectomy or wedge resection of right or left lung lobe
- American Society of Anesthesiologists physical classification (ASA PC) I-III
- Preoperative normal pulmonary function test
Exclusion Criteria:
- Anticipated difficult intubation or ventilation
- Severe heart failure (NYHA Fc >=3)
- Advanced liver cirrhosis (Child-Pugh score >=B)
- Advanced renal disease (creatinine >2 mg/dl)
- Severe anemia (hemoglobin <8 mg/dl)
- Body mass index >30
- Pregnancy
- Emergency operation
- Prior history of heart, lung or mediastinal surgery
- Psychiatric or other mental disorders
- Patient refusal
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04519606
| Taiwan | |
| E-DA hospital | |
| Kaohsiung, Taiwan, 824 | |
| Responsible Party: | Tu, Yuan-Kun, Superintendent, professor, E-DA Hospital |
| ClinicalTrials.gov Identifier: | NCT04519606 |
| Other Study ID Numbers: |
EMRP69108N |
| First Posted: | August 19, 2020 Key Record Dates |
| Last Update Posted: | October 7, 2021 |
| Last Verified: | October 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: |
|
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Barotrauma Volutrauma Biotrauma Atelectasis Lung recruitment |
|
Lung Injury Ventilator-Induced Lung Injury Lung Diseases |
Respiratory Tract Diseases Thoracic Injuries Wounds and Injuries |

